Stress testing structured finance transactions presents unique challenges due to large and diverse portfolios of underlying assets, limitations on data availability, and the idiosyncrasies and complexities of the structures and associated risks.
Stress testing US structured finance portfolios presents a unique challenge – nowhere is tail-risk analysis more critical yet more difficult to complete. As we have witnessed over the past decade, structured finance transactions tend to carry myriad risks, therefore requiring complicated analyses. In response, banks tend to separate structured finance securities from less esoteric asset classes, both organizationally and analytically. However, when a bank conducts stress testing, it must consistently apply stresses to all its positions regardless of asset class.
Looking at a structured finance portfolio as a whole can yield useful generalizations around projected performance. For example, dropping home prices are on average going to negatively affect the credit risk of RMBS tranches. However, unlike corporate bonds, for example, it is difficult to know intuitively how a change in a given macroeconomic statistic will affect a single position. Depending on deal structure, it is possible that severe economic scenarios could improve the relative performance of some tranches and cause significant losses to others. Banks cannot determine the impact on structured finance tranches without running the cash flows on the underlying properties and loans and then passing those cash flows through the deal’s waterfall. And yet, running the cash flows opens up a new set of problems, including challenges in maintaining quality data and building the underlying asset models.
Using a consistent method to stress test across asset classes implies the ability to reliably convert forecasts on a potentially large set of macroeconomic factors into performance projections on each of the bank’s positions. In the world of structured finance, this ideally means crafting projections at the underlying loan-level. The United States is one country, but each of its fifty states has unique laws and economic environments, which means granular data at the loan-level is critical. For RMBS, the state where each loan was issued has either judicial or non-judicial mortgage laws, determining how long foreclosure proceedings could last. Loan-level data can be frustratingly scarce, especially for certain structured finance asset classes like ABS, which contributes to a dearth of granular structured finance asset models.
Lower coverage for loan-level data makes it hard, if not sometimes impossible, to develop reliable account-level models in the first place. It also means that any successful stress testing model must simultaneously and consistently support alternate methodologies. As an example, consider a bank with whole loan mortgages and RMBS on its books. The whole loans may be stressed through an account-level asset model, whereas, due to weak reporting, some of the RMBS positions can only be analyzed through an aggregation model on the underlying collateral. Despite using separate models, stressed results between the whole loan and RMBS books must be consistent. Most often, missing loan-level data forces a pool-level analysis where historical performance of a given pool, its comparables, and aggregate industry and national metrics inform the projections. Mechanisms should be in place to reconcile results from the loan-level and pool-level models.
Complexities in structured finance models are not limited to the underlying assets. Many transactions include one or many swaps intended to protect against credit risk, basis risk, and so on. However, swaps themselves introduce counterparty risk. In so-called normal economic environments, counterparty risk can be overshadowed by credit risk and extension risk, as two examples, but it strongly came to the fore during the credit crisis when protective swaps failed to deliver in times of need. Indeed, counterparty risk tends to become problematic in particularly difficult economic environments, or tail-risk scenarios, which are precisely what stress testing is designed to address. Properly tracking counterparty risk within the context of structured finance securities is especially challenging given the lack of unique identifiers and standard reporting templates for derivative transactions in securitizations. Investors often need to scour performance reports and deal documents carefully to understand their counterparty exposure.
Even if a given bank has access to a model for stress testing that features consistent implementation of structured finance analysis, that bank cannot simply run the stress test once and move on. Stress testing is meant to be an ongoing process and, therefore, any competent stress testing solution must be streamlined and user-friendly. Furthermore, the platform must be extensible and diligently supported in order for the bank to keep up with the ever-changing regulatory environment. In cases where some banks hold thousands of structured finance positions, building an efficient and scalable technology infrastructure to run a variety of stress tests in a consistent and timely manner is a challenge that must be addressed.
Stress testing with a mixed portfolio that includes structured finance securities can be a daunting task. From complicated legal structures and non-standard reporting of underlying collateral to properly incorporating macroeconomic factors, some banks may struggle to convince regulators that their structured finance testing is up to the same standard as the stress testing on their more vanilla positions. This is why it is critical to leverage a platform that provides cohesion across asset classes, strong fundamental analysis, consistent assumptions and model design, and ongoing support. Consistency across all portfolio assets is imperative to stress testing best practices.
Senior Director, Sales Manager
Stephen leads Moody’s Analytics sales group for the Americas, providing off-the-shelf and customized data, software, valuations, stress testing, accounting, and advisory solutions to structured finance market participants, including hedge funds, asset management firms, banks, insurance companies, and regulators. Prior to his head of sales role, Stephen led product management, modeling, data production, customer support and implementations, and advisory services for the structured finance investor group globally. He led the EMEA and Asia-Pacific operations for the group from 2011 to 2016 and has 13 years of experience in the structured finance markets.
Explores how North American financial institutions can leverage stress testing regulations to add value to their business, for compliance and beyond.
Previous ArticleStress Testing – a Return to RAP vs. GAAP?
Next ArticleCCAR and DFAST: What will 2014 Bring?
With the release of IFRS 9 Financial Instruments, the International Accounting Standards Board set out new requirements for the accounting of financial assets, financial liabilities, and some other contracts to buy or sell non-financial assets. This paper explains the specific challenges facing structured finance investors and outlines how to effectively address these challenges.
April 2016 Pdf Stephen Clarke, Miten Amin
Preparing for the 2014 EBA Stress Test - Best Practices for Regulatory Stress Testing & Capital Modeling
This Moody's Analytics and PRMIA webinar-on-demand provides an overview of EU stress testing regulatory requirements and the Moody's Analytics capabilities and solutions that will help you meet them.
In this article, we execute the three Fed scenarios on a sample of non-agency RMBS to demonstrate how to apply one approach to both the securitized tranches and the underlying residential mortgage portfolios collateralizing the securitizations.
November 2013 WebPage Andrew Jacobs
This article addresses some of the challenges banks face in stressing their structured finance positions within the context of a larger enterprise-wide stress testing exercise.
September 2013 WebPage Stephen Clarke, Andrew Jacobs
Moody's Analytics recently reviewed our database of CLO deal performance statistics to assess relative performance across CLOs in each of the 2003 through 2007 vintages. 453 U.S. and 194 European CLO transactions were reviewed in our study and the top five deals in each vintage were selected. The ranking is presented below. While any relative performance ranking is subjective in terms of deal inclusion, parameter selection and weights, and other considerations, the underlying data used in our study is available for readers to perform their own analysis.
August 2011 Pdf Andrew Jacobs, Eugene Radomyslsky